{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:49:29Z","timestamp":1769042969925,"version":"3.49.0"},"reference-count":26,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2018,5,31]]},"DOI":"10.1536\/ihj.17-352","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T22:21:57Z","timestamp":1525818117000},"page":"482-488","source":"Crossref","is-referenced-by-count":17,"title":["Safety of Reversing Anticoagulation by Protamine Following Elective Transfemoral Percutaneous Coronary Intervention in the Drug-Eluting Stent Era"],"prefix":"10.1536","volume":"59","author":[{"given":"Shingo","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Division of Cardiology, Saitama Medical Center, Jichi Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Sakakura","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Saitama Medical Center, Jichi Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousuke","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Saitama Medical Center, Jichi Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Saitama Medical Center, Jichi Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Wada","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Saitama Medical Center, Jichi Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ichi","family":"Momomura","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Saitama Medical Center, Jichi Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Fujita","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Saitama Medical Center, Jichi Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ali ZA, Poludasu S, Qureshi YH, <i>et al<\/i>. Impact of major bleeding on long-term mortality in anemic versus nonanemic patients undergoing percutaneous coronary intervention using bivalirudin. Am J Cardiol 2014; 113: 1481-6.","DOI":"10.1016\/j.amjcard.2014.01.427"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ohno Y, Maekawa Y, Miyata H, <i>et al<\/i>. Impact of periprocedural bleeding on incidence of contrast-induced acute kidney injury in patients treated with percutaneous coronary intervention. J Am Coll Cardiol 2013; 62: 1260-6.","DOI":"10.1016\/j.jacc.2013.03.086"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Gayed M, Yadak N, Qamhia W, Daralammouri Y, Ohlow MA. Comorbidities and complications in nonagenarians undergoing coronary angiography and intervention. Int Heart J 2017; 58: 180-4.","DOI":"10.1536\/ihj.16-083"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hsueh SK, Cheng CI, Fang HY, <i>et al<\/i>. Feasibility and safety of transulnar catheterization in ipsilateral radial artery occlusion. Int Heart J 2017; 58: 313-9.","DOI":"10.1536\/ihj.16-244"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kwok CS, Kontopantelis E, Kunadian V, <i>et al<\/i>. Effect of access site, gender, and indication on clinical outcomes after percutaneous coronary intervention: Insights from the British Cardiovascular Intervention Society (BCIS). Am Heart J 2015; 170: 164-72.","DOI":"10.1016\/j.ahj.2015.04.018"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Mehta SR, Jolly SS, Cairns J, <i>et al<\/i>. Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST-segment elevation. J Am Coll Cardiol 2012; 60: 2490-9.","DOI":"10.1016\/j.jacc.2012.07.050"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Muramatsu T, Tsukahara R, Ito Y, <i>et al<\/i>. Changing strategies of the retrograde approach for chronic total occlusion during the past 7 years. Catheter Cardiovasc Interv 2013; 81: E178-85.","DOI":"10.1002\/ccd.24447"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Sakakura K, Funayama H, Taniguchi Y, <i>et al<\/i>. The incidence of slow flow after rotational atherectomy of calcified coronary arteries: A randomized study of low speed versus high speed. Catheter Cardiovasc Interv 2017; 89: 832-40.","DOI":"10.1002\/ccd.26698"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Martin JL, Pratsos A, Magargee E, <i>et al<\/i>. A randomized trial comparing compression, Perclose Proglide and Angio-Seal VIP for arterial closure following percutaneous coronary intervention: the CAP trial. Catheter Cardiovasc Interv 2008; 71: 1-5.","DOI":"10.1002\/ccd.21333"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Das R, Ahmed K, Athanasiou T, Morgan RA, Belli AM. Arterial closure devices versus manual compression for femoral haemostasis in interventional radiological procedures: a systematic review and meta-analysis. Cardiovasc Intervent Radiol 2011; 34: 723-38.","DOI":"10.1007\/s00270-010-9981-0"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Cutlip DE, Windecker S, Mehran R, <i>et al<\/i>. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007; 115: 2344-51.","DOI":"10.1161\/CIRCULATIONAHA.106.685313"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Bertrand OF, Larose E, De Larochelliere R, <i>et al<\/i>. Outpatient percutaneous coronary intervention: Ready for prime time? Can J Cardiol 2007; 23: 58B-66B.","DOI":"10.1016\/S0828-282X(07)71012-7"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Uddin M, Bundhoo S, Mitra R, <i>et al<\/i>. Femoral access PCI in a default radial center identifies high-risk patients with poor outcomes. J Interv Cardiol 2015; 28: 485-92.","DOI":"10.1111\/joic.12226"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Baber U, Mehran R, Giustino G, <i>et al<\/i>. Coronary thrombosis and major bleeding after PCI with drug-eluting stents: Risk scores rrom PARIS. J Am Coll Cardiol 2016; 67: 2224-34.","DOI":"10.1016\/j.jacc.2016.02.064"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Numasawa Y, Inohara T, Ishii H, <i>et al<\/i>. Comparison of outcomes of women versus men with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary intervention (from the Japanese Nationwide Registry). Am J Cardiol 2017; 119: 826-31.","DOI":"10.1016\/j.amjcard.2016.11.034"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Koeth O, Gulba D, Huber K, <i>et al<\/i>. Independent predictors of bleeding complications in patients undergoing PCI with concomitant treatment with bivalirudin in clinical practice results from the ImproveR registry. J Cardiovasc Pharmacol 2013; 62: 507-11.","DOI":"10.1097\/FJC.0000000000000005"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kwok CS, Sherwood MW, Watson SM, <i>et al<\/i>. Blood transfusion after percutaneous coronary intervention and risk of subsequent adverse outcomes: a systematic review and meta-analysis. JACC Cardiovasc Interv 2015; 8: 436-46.","DOI":"10.1016\/j.jcin.2014.09.026"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Maree AO, Margey RJ, Selzer F, <i>et al<\/i>. Renal insufficiency, bleeding and prescription of discharge medication in patients undergoing percutaneous coronary intervention in the National Heart, Lung, and Blood Institute (NHLBI) Dynamic Registry. Cardiovasc Revasc Med 2016; 17: 302-7.","DOI":"10.1016\/j.carrev.2016.03.002"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Berger RL, Ramaswamy K, Ryan TJ. Reduced protamine dosage for heparin neutralization in open-heart operations. Circulation 1968; 37: II154-7.","DOI":"10.1161\/01.CIR.37.4S2.II-154"},{"key":"20","first-page":"66","volume":"1","year":"2005","unstructured":"20. Thuesen L, Andersen HR, Botker HE, Dalby Kristensen S, Krusell LR, Lassen JF. In-laboratory femoral sheath removal after heparin reversal by protamine after percutaneous coronary intervention. EuroIntervention 2005; 1: 66-9.","journal-title":"EuroIntervention","ISSN":"https:\/\/id.crossref.org\/issn\/1774-024X","issn-type":"print"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ducas J, Chan MC, Miller A, Kashour T. Immediate protamine administration and sheath removal following percutaneous coronary intervention: a prospective study of 429 patients. Catheter Cardiovasc Interv 2002; 56: 196-9.","DOI":"10.1002\/ccd.10195"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Mehran R, Pocock S, Nikolsky E, <i>et al<\/i>. Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials. JACC Cardiovasc Interv 2011; 4: 654-64.","DOI":"10.1016\/j.jcin.2011.02.011"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Yatskar L, Selzer F, Feit F, <i>et al<\/i>. Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: data from the National Heart, Lung, and Blood Institute Dynamic Registry. Catheter Cardiovasc Interv 2007; 69: 961-6.","DOI":"10.1002\/ccd.21087"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Mochizuki T, Olson PJ, Szlam F, Ramsay JG, Levy JH. Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass. Anesth Analg 1998; 87: 781-5.","DOI":"10.1213\/00000539-199810000-00008"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Brown CG, Kelen GD, Ashton JJ, Werman HA. The beta error and sample size determination in clinical trials in emergency medicine. Ann Emerg Med 1987; 16: 183-7.","DOI":"10.1016\/S0196-0644(87)80013-6"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Montalescot G, Wiviott SD, Braunwald E, <i>et al<\/i>. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. Lancet 2009; 373: 723-31.","DOI":"10.1016\/S0140-6736(09)60441-4"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/59\/3\/59_17-352\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T20:56:35Z","timestamp":1661201795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/59\/3\/59_17-352\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,31]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.17-352","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,31]]}}}